The article comments on the study which evaluated fenoldopam to prevent acute renal failure in high-risk patients. The author cited that the research suggested patient-important benefits and a clinically tolerable increased for hypotension. It was found out that fenoldopam reduces acute kidney injury and death in critical illness.